potassium chloride 1.33 MEQ/ML Oral Solution
potassium chloride
RxCUI: 312515
What the CMS Formulary Data Shows for potassium chloride 1.33 MEQ/ML Oral Solution
Per the CMS 2026 Part D formulary file, potassium chloride 1.33 MEQ/ML Oral Solution (RxNorm concept RXCUI 312515, generic name potassium chloride) appears on 329 distinct formulary files spanning 5,058 Medicare Part D plan offerings - 99.8% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.9.
Real-world access to potassium chloride 1.33 MEQ/ML Oral Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,479,756 Part D beneficiaries filled potassium chloride 1.33 MEQ/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $396,202,925 and an average per-beneficiary annual cost of $113.86. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry potassium chloride 1.33 MEQ/ML Oral Solution today.
Coverage Details
- Formularies covering
- 329
- Plans covering
- 5,058
- Coverage rate
- 99.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,479,756
- Total spending
- $396,202,925
- Avg per beneficiary
- $113.86
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering potassium chloride 1.33 MEQ/ML Oral Solution
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Anthem Full Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Kidney Care (HMO-POS C-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Full Dual Advantage Select (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering potassium chloride 1.33 MEQ/ML Oral Solution
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is potassium chloride 1.33 MEQ/ML Oral Solution covered by Medicare Part D?
Yes, potassium chloride 1.33 MEQ/ML Oral Solution is covered by 5,058 Medicare Part D plans (99.8% of all Part D formularies).
What tier is potassium chloride 1.33 MEQ/ML Oral Solution on Medicare Part D plans?
potassium chloride 1.33 MEQ/ML Oral Solution averages Tier 2.9 across Part D plans, ranging from Tier 1 to Tier 4.
Does potassium chloride 1.33 MEQ/ML Oral Solution require prior authorization?
0% of Part D formularies require prior authorization for potassium chloride 1.33 MEQ/ML Oral Solution. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on potassium chloride 1.33 MEQ/ML Oral Solution?
In 2023, total Medicare Part D spending on potassium chloride 1.33 MEQ/ML Oral Solution was $396,202,925, covering 3,479,756 beneficiaries. The average spend per beneficiary was $113.86.
Read our methodology - how this data is sourced, computed, and verified.